Literature DB >> 28262250

Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion.

Steven J Pennybaker1, David A Luckenbaugh2, Lawrence T Park2, Craig A Marquardt3, Carlos A Zarate4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28262250      PMCID： PMC5859935          DOI： 10.1016/j.biopsych.2016.08.041

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  6 in total

1.  The Use of Ketamine for the Treatment of Depression in the Context of Psychotic Symptoms: To the Editor.

Authors:  Carolina Medeiros da Frota Ribeiro; Gerard Sanacora; Ralph Hoffman; Robert Ostroff
Journal:  Biol Psychiatry       Date:  2015-06-04       Impact factor: 13.382

2.  Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.

Authors:  Ke Xu; John H Krystal; Yuping Ning; Da Chun Chen; Hongbo He; Daping Wang; Xiaoyin Ke; Xifan Zhang; Yi Ding; Yuping Liu; Ralitza Gueorguieva; Zuoheng Wang; Diana Limoncelli; Robert H Pietrzak; Ismene L Petrakis; Xiangyang Zhang; Ni Fan
Journal:  J Psychiatr Res       Date:  2014-12-24       Impact factor: 4.791

3.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Authors:  Nancy Diazgranados; Lobna Ibrahim; Nancy E Brutsche; Andrew Newberg; Phillip Kronstein; Sami Khalife; William A Kammerer; Zenaide Quezado; David A Luckenbaugh; Giacomo Salvadore; Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Arch Gen Psychiatry       Date:  2010-08

4.  Effects of ketamine in normal and schizophrenic volunteers.

Authors:  A C Lahti; M A Weiler; B A Tamara Michaelidis; A Parwani; C A Tamminga
Journal:  Neuropsychopharmacology       Date:  2001-10       Impact factor: 7.853

5.  Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

Authors:  Carlos A Zarate; Nancy E Brutsche; Lobna Ibrahim; Jose Franco-Chaves; Nancy Diazgranados; Anibal Cravchik; Jessica Selter; Craig A Marquardt; Victoria Liberty; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-01-31       Impact factor: 13.382

Review 6.  A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.

Authors:  A McGirr; M T Berlim; D J Bond; M P Fleck; L N Yatham; R W Lam
Journal:  Psychol Med       Date:  2014-07-10       Impact factor: 7.723
  6 in total
  2 in total

Review 1.  Advantages of ketamine in pediatric anesthesia.

Authors:  Alessandro Simonini; Etrusca Brogi; Marco Cascella; Alessandro Vittori
Journal:  Open Med (Wars)       Date:  2022-07-06

Review 2.  Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.

Authors:  Felicia Ceban; Joshua D Rosenblat; Kevin Kratiuk; Yena Lee; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Flora Nasri; Leanna M W Lui; Orly Lipsitz; Anil Kumar; Jung Goo Lee; Edmond H Chau; Bing Cao; Kangguang Lin; Roger C Ho; Rodrigo B Mansur; Jennifer Swainson; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-08-07       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.